Innovative Technology Platforms
Our proprietary platforms enable faster, more efficient antibody discovery, engineering, and evaluation.
DiMPro™ Membrane Protein Platform
Utilizes HEK293 mammalian expression system to produce functional membrane proteins with authentic post-translational modifications. Offers five solutions: MNP, VLP, EXO, Detergent, and Synthetic Nanodisc.
- • 500+ active full-length multi-pass proteins
- • High solubility & correct folding
- • Ideal for GPCRs, ion channels
Single B Cell mAb Platform
Direct isolation of positive B cells from immunized animals eliminates hybridoma fusion. Enables sequencing of over 1,000 positive clones per animal with higher hit rates.
- • No hybridoma required
- • 10,000+ hits in one month
- • High positive clone rate
DiLibrary™ Mammalian Display
One-step antibody engineering platform for humanization, chimerization, and affinity maturation. Delivers results in 48 days with superior developability.
- • 48-day turnaround
- • $20K–$40K cost range
- • High affinity retention
DiAssay™ Evaluation Platform
Comprehensive screening for optimal hit molecules across multiple modalities: Bispecifics, ADCs, and CAR-T therapies.
- • Bispecific Antibody screening
- • ADC internalization assays
- • CAR-T functional evaluation
Functional TP Development
Focuses on transmembrane protein expression and functional characterization using mammalian systems for high biological relevance.
- • Full-length protein production
- • Activity-confirmed batches
- • SPR-ready formats
DiNabody™ Nanobody Discovery
Advanced nanobody discovery service using camelid immunization and high-throughput screening for small, stable, high-affinity binders.
- • High thermal stability
- • Deep tissue penetration
- • Ideal for diagnostics & imaging